Matches in SemOpenAlex for { <https://semopenalex.org/work/W1995314920> ?p ?o ?g. }
- W1995314920 endingPage "9" @default.
- W1995314920 startingPage "1" @default.
- W1995314920 abstract "Objective:Anticoagulant effect of LMWHs is monitored by anti-factor Xa (anti-FXa) activity assay. Since this test has several limitations, the aim of this study was to explore the activity of two LMWHs by thrombin generation assay (TG, which presents an overall picture of hemostatic balance) and its correlation with their anti-FXa activity.Methods:In an open-label, randomized cross-over study, 40 mg of two enoxaparins, the original branded formulation (R) and another one, also marketed in Argentina (T), were daily injected subcutaneously, for 7 days, to 20 healthy volunteers, with a 7-day washout interval. Blood samples were collected before treatment and 180 minutes after the injection on days 3 and 7. TG in platelet-poor plasma activated with tissue factor was assessed by lag time (LT), time to peak (TTP), peak (PTG), and endogenous thrombin potential (ETP). Anti-FXa and anti-FIIa activities, free tissue factor pathway inhibitor (free TFPI), tissue plasminogen activator (t-PA), plasminogen activator inhibitor type 1 (PAI-1), and euglobulin lysis time (ELT) were also assayed.Results:The mean (SD) anti-FXa (UI/ml) for T and R increased on days 3 and 7. LT and TTP were significantly prolonged by both LMWHs, with no differences between them. The mean ETP (nmol/L) for T and R at 3 and 7 days after treatment were significantly reduced when compared with basal values (p = 0.001 for all). On day 3, a significant correlation was shown between the variables describing TG and anti-FXa for T and R, without differences between them, for LT (r: 0.516 and 0486), ETP (r: 0.532 and 0.574), PEAK (r: 0.482 and 0.501), and TTP (r: 0.577 and 0.503), respectively. This correlation was also significant on day 7. Anti-FIIa activity and free TFPI increased significantly at 3 and 7 days for both LMWHs, without differences between them. R and T decreased ELT and PAI-1, but had no effect on t-PA. There were no differences between both LMWHs in routine hemostatic tests. No adverse events were reported.Conclusions:Correlation between TG and anti-FXa activity was good. Both enoxaparins induced similar change of coagulation parameters, with a significant increase in fibrinolytic activity." @default.
- W1995314920 created "2016-06-24" @default.
- W1995314920 creator A5010971366 @default.
- W1995314920 creator A5012221077 @default.
- W1995314920 creator A5013847950 @default.
- W1995314920 creator A5050878005 @default.
- W1995314920 creator A5059785414 @default.
- W1995314920 creator A5077510263 @default.
- W1995314920 creator A5080627010 @default.
- W1995314920 date "2010-11-18" @default.
- W1995314920 modified "2023-09-26" @default.
- W1995314920 title "Effects of enoxaparin preparations on thrombin generation and their correlation with their anti-FXa activity" @default.
- W1995314920 cites W1494227535 @default.
- W1995314920 cites W1729992368 @default.
- W1995314920 cites W1761929150 @default.
- W1995314920 cites W1969712524 @default.
- W1995314920 cites W1974733818 @default.
- W1995314920 cites W1974780454 @default.
- W1995314920 cites W1987940917 @default.
- W1995314920 cites W1993893409 @default.
- W1995314920 cites W1994238439 @default.
- W1995314920 cites W1998317810 @default.
- W1995314920 cites W1999385881 @default.
- W1995314920 cites W2000305246 @default.
- W1995314920 cites W2000488259 @default.
- W1995314920 cites W2023394373 @default.
- W1995314920 cites W2029474671 @default.
- W1995314920 cites W2035681917 @default.
- W1995314920 cites W2050226103 @default.
- W1995314920 cites W2054962585 @default.
- W1995314920 cites W2064849355 @default.
- W1995314920 cites W2070377287 @default.
- W1995314920 cites W2073265922 @default.
- W1995314920 cites W2079072220 @default.
- W1995314920 cites W2083342642 @default.
- W1995314920 cites W2085433233 @default.
- W1995314920 cites W2086443301 @default.
- W1995314920 cites W2115696508 @default.
- W1995314920 cites W2135486988 @default.
- W1995314920 cites W2136218830 @default.
- W1995314920 cites W2148955503 @default.
- W1995314920 cites W2154555691 @default.
- W1995314920 cites W2217969591 @default.
- W1995314920 cites W74963018 @default.
- W1995314920 doi "https://doi.org/10.1185/03007995.2010.535512" @default.
- W1995314920 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21083516" @default.
- W1995314920 hasPublicationYear "2010" @default.
- W1995314920 type Work @default.
- W1995314920 sameAs 1995314920 @default.
- W1995314920 citedByCount "6" @default.
- W1995314920 countsByYear W19953149202013 @default.
- W1995314920 countsByYear W19953149202014 @default.
- W1995314920 countsByYear W19953149202019 @default.
- W1995314920 countsByYear W19953149202021 @default.
- W1995314920 countsByYear W19953149202022 @default.
- W1995314920 crossrefType "journal-article" @default.
- W1995314920 hasAuthorship W1995314920A5010971366 @default.
- W1995314920 hasAuthorship W1995314920A5012221077 @default.
- W1995314920 hasAuthorship W1995314920A5013847950 @default.
- W1995314920 hasAuthorship W1995314920A5050878005 @default.
- W1995314920 hasAuthorship W1995314920A5059785414 @default.
- W1995314920 hasAuthorship W1995314920A5077510263 @default.
- W1995314920 hasAuthorship W1995314920A5080627010 @default.
- W1995314920 hasConcept C126322002 @default.
- W1995314920 hasConcept C1621761 @default.
- W1995314920 hasConcept C186738567 @default.
- W1995314920 hasConcept C2776572282 @default.
- W1995314920 hasConcept C2777151630 @default.
- W1995314920 hasConcept C2777292125 @default.
- W1995314920 hasConcept C2778382381 @default.
- W1995314920 hasConcept C2779679481 @default.
- W1995314920 hasConcept C2909373784 @default.
- W1995314920 hasConcept C71924100 @default.
- W1995314920 hasConcept C89560881 @default.
- W1995314920 hasConcept C98274493 @default.
- W1995314920 hasConceptScore W1995314920C126322002 @default.
- W1995314920 hasConceptScore W1995314920C1621761 @default.
- W1995314920 hasConceptScore W1995314920C186738567 @default.
- W1995314920 hasConceptScore W1995314920C2776572282 @default.
- W1995314920 hasConceptScore W1995314920C2777151630 @default.
- W1995314920 hasConceptScore W1995314920C2777292125 @default.
- W1995314920 hasConceptScore W1995314920C2778382381 @default.
- W1995314920 hasConceptScore W1995314920C2779679481 @default.
- W1995314920 hasConceptScore W1995314920C2909373784 @default.
- W1995314920 hasConceptScore W1995314920C71924100 @default.
- W1995314920 hasConceptScore W1995314920C89560881 @default.
- W1995314920 hasConceptScore W1995314920C98274493 @default.
- W1995314920 hasIssue "1" @default.
- W1995314920 hasLocation W19953149201 @default.
- W1995314920 hasLocation W19953149202 @default.
- W1995314920 hasOpenAccess W1995314920 @default.
- W1995314920 hasPrimaryLocation W19953149201 @default.
- W1995314920 hasRelatedWork W1860372928 @default.
- W1995314920 hasRelatedWork W1949117963 @default.
- W1995314920 hasRelatedWork W195015772 @default.
- W1995314920 hasRelatedWork W2070396494 @default.
- W1995314920 hasRelatedWork W2073096151 @default.
- W1995314920 hasRelatedWork W2103356587 @default.